- Home
- IPHA vs RELL Comparison
IPHA vs RELL Comparison
Compare IPHA & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- RELL
- Stock Information
- Founded
- IPHA 1999
- RELL 1947
- Country
- IPHA France
- RELL United States
- Employees
- IPHA N/A
- RELL N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- RELL Electronic Components
- Sector
- IPHA Health Care
- RELL Technology
- Exchange
- IPHA Nasdaq
- RELL Nasdaq
- Market Cap
- IPHA 178.0M
- RELL 202.2M
- IPO Year
- IPHA 2019
- RELL N/A
- Fundamental
- Price
- IPHA $2.07
- RELL $13.77
- Analyst Decision
- IPHA Strong Buy
- RELL
- Analyst Count
- IPHA 1
- RELL 0
- Target Price
- IPHA $11.50
- RELL N/A
- AVG Volume (30 Days)
- IPHA 1.5M
- RELL 65.7K
- Earning Date
- IPHA 09-12-2024
- RELL 01-08-2025
- Dividend Yield
- IPHA N/A
- RELL 1.71%
- EPS Growth
- IPHA N/A
- RELL N/A
- EPS
- IPHA N/A
- RELL N/A
- Revenue
- IPHA $36,202,722.00
- RELL $197,604,000.00
- Revenue This Year
- IPHA N/A
- RELL $15.93
- Revenue Next Year
- IPHA $102.87
- RELL $11.34
- P/E Ratio
- IPHA N/A
- RELL N/A
- Revenue Growth
- IPHA N/A
- RELL N/A
- 52 Week Low
- IPHA $1.29
- RELL $8.08
- 52 Week High
- IPHA $3.51
- RELL $15.51
- Technical
- Relative Strength Index (RSI)
- IPHA 53.12
- RELL 42.82
- Support Level
- IPHA $1.47
- RELL $13.82
- Resistance Level
- IPHA $2.36
- RELL $15.51
- Average True Range (ATR)
- IPHA 0.32
- RELL 0.52
- MACD
- IPHA 0.06
- RELL -0.08
- Stochastic Oscillator
- IPHA 29.99
- RELL 21.24
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.